Patrick J. McEnany is CEO & President at CATALYST PHARMACEUTICALS, INC. (CPRX). They have made 46 open-market trades across 2 companies since 2008, most recently 2025-12-29.
CIK 0000929985
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
36 open-market purchases totalling $1.2M since 2008, against 10 sales. Across 36 scored buys the stock is up 3.7% at ninety days, and 1.9 points ahead of the S&P over the same stretch.
36 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 19% | 25% |
| Avg Move | -13.4% | -2.4% | +3.7% |
| Alpha | -9.2% | -3.0% | +1.9% |
| Scored | 36 | 36 | 36 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CPRX | SELL | 2025-06-06 | 2025-06-10 | $26.09 | $10.4M | -16.3% | -17.4% | -24.1% |
| CPRX | SELL | 2024-11-19 | 2024-11-21 | $21.22 | $5.7M | +3.7% | +2.0% | +6.4% |
| CPRX | SELL | 2024-11-13 | 2024-11-15 | $22.38 | $4.1M | +7.6% | +4.3% | +12.0% |
| CPRX | SELL | 2024-11-11 | 2024-11-13 | $23.40 | $13.1M | -6.9% | -6.1% | -0.8% |
| CPRX | SELL | 2023-05-15 | 2023-05-17 | $13.23 | $692K | -8.3% | -3.2% | +18.9% |
| CPRX | SELL | 2022-11-18 | 2022-11-22 | $15.53 | $7.8M | -2.7% | +10.9% | -12.6% |
| CPRX | SELL | 2022-09-13 | 2022-09-15 | $15.40 | $31.7M | -5.1% | -0.2% | +35.4% |
| CPRX | SELL | 2022-08-18 | 2022-08-19 | $14.01 | $4.2M | -2.9% | -7.0% | +9.7% |
| CPRX | SELL | 2021-08-20 | 2021-08-24 | $5.59 | $1.5M | -5.6% | -9.2% | +30.8% |
| CPRX | SELL | 2021-08-13 | 2021-08-17 | $6.12 | $768K | -4.2% | -13.0% | +27.8% |
| CPRX | BUY | 2020-09-30 | 2020-09-30 | $2.97 | $45K | +6.6% | -1.7% | +11.6% |
| CPRX | BUY | 2019-10-03 | 2019-10-03 | $4.89 | $49K | +7.2% | -4.9% | -23.2% |
| CPRX | BUY | 2019-06-11 | 2019-06-11 | $3.23 | $81K | +1.1% | +15.0% | +87.3% |
| CPRX | BUY | 2018-12-19 | 2018-12-19 | $2.24 | $45K | -6.6% | +15.9% | +54.0% |
| CPRX | BUY | 2018-04-03 | 2018-04-03 | $2.29 | $46K | +10.9% | +19.2% | +44.1% |
| CPRX | BUY | 2017-09-05 | 2017-09-05 | $2.58 | $52K | -2.0% | +8.9% | +76.0% |
| CPRX | BUY | 2016-06-14 | 2016-06-14 | $0.65 | $68K | +11.8% | +7.1% | +39.6% |
| CPRX | BUY | 2016-04-26 | 2016-04-26 | $0.65 | $33K | -3.4% | -3.8% | +18.6% |
| CPRX | BUY | 2015-12-28 | 2015-12-28 | $2.39 | $60K | -17.6% | -19.7% | -51.6% |
| CPRX | BUY | 2015-10-01 | 2015-10-01 | $2.81 | $28K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2015-04-27 | 2015-04-27 | $3.79 | $19K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2015-01-08 | 2015-01-08 | $2.80 | $140K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2014-05-21 | 2014-05-21 | $1.89 | $47K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2014-02-07 | 2014-02-07 | $1.82 | $46K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2013-10-21 | 2013-10-21 | $1.59 | $80K | -17.6% | -4.9% | -4.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.